PIDC is excited to announce the embarkment on the next chapter of development for the Navy Yard’s future. PIDC and its consultant, AECOM, will collaborate with everyone in the Philadelphia community – including you! – to develop the Navy Yard Connected Community Plan, a strategic plan that will connect businesses, employees, visitors, and future residents through innovative initiatives, technologies, resources, and amenities.
Adaptimmune Therapeutics plc. (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced plans to locate its U.S. headquarters and clinical operations in a newly developed facility to be constructed at The Navy Yard in Philadelphia. The 47,400 square foot facility, located at 351 Rouse Boulevard in The Navy Yard’s Corporate Center, will house a state-of-the-art cGMP manufacturing facility designed to support the clinical development and initial commercialization of the Company’s novel engineered immunotherapies for cancer. Read more